| Title |
Pharmacotherapy for anxiety and comorbid alcohol use disorders
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2015
|
| DOI | 10.1002/14651858.cd007505.pub2 |
| Pubmed ID | |
| Authors |
Jonathan C Ipser, Don Wilson, Taiwo O Akindipe, Carli Sager, Dan J Stein |
| Abstract |
Anxiety disorders are a potentially disabling group of disorders that frequently co-occur with alcohol use disorders. Comorbid anxiety and alcohol use disorders are associated with poorer outcomes, and are difficult to treat with standard psychosocial interventions. In addition, improved understanding of the biological basis of the conditions has contributed to a growing interest in the use of medications for the treatment of people with both diagnoses. |
X Demographics
The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 2 | 17% |
| Spain | 2 | 17% |
| United States | 2 | 17% |
| India | 1 | 8% |
| Unknown | 5 | 42% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 75% |
| Practitioners (doctors, other healthcare professionals) | 2 | 17% |
| Scientists | 1 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 432 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Unknown | 431 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 66 | 15% |
| Researcher | 59 | 14% |
| Student > Bachelor | 50 | 12% |
| Student > Ph. D. Student | 31 | 7% |
| Student > Doctoral Student | 25 | 6% |
| Other | 76 | 18% |
| Unknown | 125 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 126 | 29% |
| Psychology | 59 | 14% |
| Nursing and Health Professions | 23 | 5% |
| Social Sciences | 15 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 3% |
| Other | 52 | 12% |
| Unknown | 142 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 December 2020.
All research outputs
#2,609,942
of 25,632,496 outputs
Outputs from Cochrane database of systematic reviews
#5,227
of 13,152 outputs
Outputs of similar age
#35,131
of 361,390 outputs
Outputs of similar age from Cochrane database of systematic reviews
#113
of 289 outputs
Altmetric has tracked 25,632,496 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,152 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.6. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,390 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 289 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.